| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/15/2002 | EP1204657A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204639A1 Synthesis of a novel paramagnetic amino acid derivative (epm-5) for labelling chemical and biological macromolecules |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | CN1349535A Bicyclic heteroaromatic compounds useful as LH agonists |
| 05/15/2002 | CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1348954A Prepn of N-bromosuccinimide |
| 05/15/2002 | CN1084744C N-substituted azaheterocyclic compounds |
| 05/15/2002 | CN1084734C Anhydrous crystals |
| 05/14/2002 | US6388123 Substituted phenyl keto enols as pesticides and herbicides |
| 05/14/2002 | US6388122 Tryptase inhibitor and novel guanidino derivatives |
| 05/14/2002 | US6387949 Substituted urea compounds useful in pain management |
| 05/14/2002 | US6387941 Antiserotonine agents |
| 05/14/2002 | US6387937 Indole derivatives |
| 05/10/2002 | WO2002036641A2 Improved productivity catalysts and microstructure control |
| 05/10/2002 | WO2002036585A2 Process for the preparation of ligands for olefin polymerization catalysts |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036560A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | WO2002036544A1 Method of resolving optical isomers of amino acid derivative |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | CA2425286A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/09/2002 | US20020055534 Method for treating neurodegeneration |
| 05/09/2002 | US20020055469 Anticoagulants |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203585A1 Anti-ischemic agent |
| 05/08/2002 | EP1203047A1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202962A1 Pyrrolidine compounds and their use for treating hyperproliferative diseases and tumor diseases |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202956A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384069 Brain disorders chronic pain, hypoglycemia, hypoxia, trauma, alzheimer's disease, aids-associated dementia, amyotrophic lateral sclerosis, parkinson's disease, and chronic alcoholism, comprising administering to a patient in need a |
| 05/07/2002 | US6384063 Compound having effect of promoting neuron differentiation |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/02/2002 | WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2002034698A2 Phosgene-free process for preparing carbamates |
| 05/02/2002 | WO2002004416A3 Lactam metalloprotease inhibitors |
| 05/02/2002 | WO2001085675A3 Fluorous tagging compounds and their use |
| 05/02/2002 | WO2001052829A3 Statin-type bone growth stimulators |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052502 Cis-substituted aminocyclopropane derivative |
| 05/02/2002 | US20020052410 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 05/02/2002 | US20020052003 Composition for use in the adhesion of particle to surfaces |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1201239A1 Cyclic amine ccr3 antagonists |
| 05/02/2002 | EP1200457A2 Cysteine protease inhibitors |
| 05/02/2002 | EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 05/02/2002 | EP1200402A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 05/02/2002 | EP1200401A1 Method for producing protected acyl guanidines by way of mukaiyama reaction |
| 05/02/2002 | EP1200400A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200083A1 Antibiotic compound |
| 05/02/2002 | CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 05/02/2002 | CA2426466A1 Phosgene-free process for preparing carbamates |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/01/2002 | CN1347423A Catalyst contg. N-pyrrolyl substd. nitrogen donors |
| 04/30/2002 | US6380398 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv) |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
| 04/30/2002 | US6380241 For therapy of coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporin-induced nephrotoxicity, endotoxin-induced toxicity, asthma, lpl-related lipoprotein disorders, proliferative diseases |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380181 Synthetic catechol derivatives, method for production and use thereof |
| 04/30/2002 | US6380149 Using mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, and perfluorocycloalkyl(ene)-containing perfluoroalkane, optionally with catenary heteroatoms, and a cosolvent; good solvency, ozone depletion potential of zero |
| 04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
| 04/30/2002 | US6379588 Stabilized monomer composition |
| 04/27/2002 | CA2539147A1 Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 04/25/2002 | WO2002033026A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032871A2 Compounds and methods for treating multidrug resistance |
| 04/25/2002 | WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032376A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs |